Iguana Healthcare Management as of Dec. 31, 2014
Portfolio Holdings for Iguana Healthcare Management
Iguana Healthcare Management holds 52 positions in its portfolio as reported in the December 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biogen Idec (BIIB) | 8.2 | $17M | 50k | 339.45 | |
| Celgene Corporation | 6.0 | $12M | 110k | 111.86 | |
| Gilead Sciences (GILD) | 5.7 | $12M | 125k | 94.26 | |
| Medtronic | 5.2 | $11M | 150k | 72.20 | |
| Acceleron Pharma | 4.5 | $9.4M | 240k | 38.96 | |
| Health Care SPDR (XLV) | 4.1 | $8.5M | 125k | 68.38 | |
| Esperion Therapeutics (ESPR) | 3.9 | $8.1M | 200k | 40.44 | |
| Impax Laboratories | 3.1 | $6.3M | 200k | 31.68 | |
| Receptos | 3.0 | $6.1M | 50k | 122.52 | |
| Mylan | 2.7 | $5.6M | 100k | 56.37 | |
| Amgen (AMGN) | 2.7 | $5.6M | 35k | 159.29 | |
| Abbvie (ABBV) | 2.4 | $4.9M | 75k | 65.44 | |
| SPDR S&P Biotech (XBI) | 2.2 | $4.7M | 25k | 186.48 | |
| Sanofi-Aventis SA (SNY) | 2.2 | $4.6M | 100k | 45.61 | |
| Aerie Pharmaceuticals | 2.1 | $4.4M | 150k | 29.19 | |
| Merck & Co (MRK) | 2.1 | $4.3M | 75k | 56.79 | |
| Shire | 2.0 | $4.3M | 20k | 212.55 | |
| Supernus Pharmaceuticals (SUPN) | 2.0 | $4.2M | 500k | 8.30 | |
| Gw Pharmaceuticals Plc ads | 2.0 | $4.1M | 60k | 67.68 | |
| Tornier Nv | 1.9 | $3.8M | 150k | 25.50 | |
| Tenet Healthcare Corporation (THC) | 1.8 | $3.8M | 75k | 50.67 | |
| Volcano Corporation | 1.7 | $3.6M | 200k | 17.88 | |
| EnteroMedics | 1.7 | $3.5M | 2.4M | 1.42 | |
| AVANIR Pharmaceuticals | 1.6 | $3.4M | 200k | 16.95 | |
| Aratana Therapeutics | 1.6 | $3.2M | 180k | 17.82 | |
| Wright Medical | 1.5 | $3.1M | 115k | 26.87 | |
| Chimerix (CMRX) | 1.5 | $3.0M | 75k | 40.27 | |
| Alkermes (ALKS) | 1.4 | $2.9M | 50k | 58.56 | |
| Novadaq Technologies | 1.4 | $2.9M | 175k | 16.62 | |
| Zimmer Holdings (ZBH) | 1.4 | $2.8M | 25k | 113.44 | |
| Horizon Pharma | 1.2 | $2.6M | 200k | 12.89 | |
| Quidel Corporation | 1.2 | $2.5M | 85k | 28.90 | |
| Dyax | 1.2 | $2.5M | 175k | 14.06 | |
| Achillion Pharmaceuticals | 1.2 | $2.5M | 200k | 12.25 | |
| Pfizer (PFE) | 1.1 | $2.3M | 75k | 31.15 | |
| Ultragenyx Pharmaceutical (RARE) | 1.1 | $2.2M | 50k | 43.88 | |
| OraSure Technologies (OSUR) | 1.0 | $2.0M | 200k | 10.14 | |
| Puma Biotechnology (PBYI) | 0.9 | $1.9M | 10k | 189.30 | |
| Celldex Therapeutics | 0.9 | $1.8M | 100k | 18.25 | |
| Spectranetics Corporation | 0.8 | $1.7M | 50k | 34.58 | |
| Syneron Medical Ltd ord | 0.8 | $1.6M | 175k | 9.33 | |
| Rite Aid Corporation | 0.7 | $1.5M | 200k | 7.52 | |
| Flexion Therapeutics | 0.7 | $1.5M | 75k | 20.19 | |
| Mei Pharma | 0.7 | $1.5M | 350k | 4.27 | |
| Cymabay Therapeutics | 0.6 | $1.2M | 125k | 9.83 | |
| Accelr8 Technology | 0.5 | $960k | 50k | 19.20 | |
| BioCryst Pharmaceuticals (BCRX) | 0.4 | $912k | 75k | 12.16 | |
| Dermira | 0.4 | $906k | 50k | 18.12 | |
| Nektar Therapeutics (NKTR) | 0.4 | $775k | 50k | 15.50 | |
| Keryx Biopharmaceuticals | 0.2 | $425k | 30k | 14.17 | |
| Assembly Biosciences | 0.2 | $393k | 50k | 7.86 | |
| Endologix | 0.2 | $382k | 25k | 15.28 |
